Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Tumor expression of TTF1 is associated with a doubling of overall survival in patients with advanced lung adenocarcinomas
    Meeting Abstract

    Hellmann, M. D.; Hilden, P. D.; Sima, C. S.; Kris, M. G.; Rekhtman, N.; Chaft, J. E.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • "Intention-to-treat" outcomes of sequential patients with stage IIIA lung adenocarcinomas treated with neoadjuvant chemotherapy with intent of surgical resection
    Meeting Abstract

    Hellmann, M. D.; Chaft, J. E.; Hilden, P. D.; Rusch, V. W.; Kris, M. G.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Erlotinib versus radiation therapy for brain metastases in patients with EGFR-mutant lung adenocarcinoma
    Meeting Abstract

    Gerber, N. K.; Yamada, Y.; Shi, W. J.; Zhang, Z. G.; Riely, G.; Beal, K.; Yu, H. A.; Chan, T. A.; Rimner, A.; Wu, A. J.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • A phase 1 dose escalation study of a new ALK inhibitor, CH5424802/RO5424802, in ALK+ non-small cell lung cancer (NSCLC) patients who have failed crizotinib (AF-002JG/NP28761, NCT01588028)
    Meeting Abstract

    Gadgeel, S.; Ou, S. H.; Chiappori, A. A.; Riely, G.; Lee, R. M.; Garcia, L.; Sato, J.; Yokoyama, S.; Tanaka, T.; Gandhi, L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Ret fusion-positive advanced lung cancers: Response to first-line chemotherapy and survival in comparison to ROS1 and ALK fusion-positive and EGFR- and KRAS-mutant lung cancers
    Meeting Abstract

    Drilon, A.; Wang, L.; Joubert, P.; Snyder, A.; Cho, E. J.; Riely, G.; Kris, M.; Ladanyi, M.; Rizvi, N.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Histological prognostic markers in squamous cell carcinoma of the lung
    Meeting Abstract

    Drilon, A.; Sima, C. S.; Paik, P. K.; Moreira, A. L.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Evaluation of tolerability and anti-tumor activity of GDC-0980, an oral PI3K/mTOR inhibitor, administered to patients with advanced malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Dolly, S. O.; Krug, L. M.; Wagner, A. J.; Schwartz, L. H.; Bendell, J. C.; Lauchle, J. O.; Seiwert, T. Y.; Rihawi, K.; Tunariu, N.; Zauderer, M. G.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • High local control rates with postoperative radiation therapy in incompletely resected non-small cell lung cancer (NSCLC) patients
    Meeting Abstract

    Din, S. U.; Wu, A. J.; Gelblum, D. Y.; Foster, A.; Chaft, J. E.; Rizk, N. P.; Huang, J.; Rimner, A.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical, structural and biochemical characterization of EGFR exon 20 insertion mutations in lung cancer
    Meeting Abstract

    Costa, D. B.; Yasuda, H.; Park, E.; Yun, C. H.; Huberman, M. S.; Oxnard, G. R.; Sequist, L. V.; Riely, G.; Soo, R.; Eck, M. J.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Clinical experience with crizotinib in patients with advanced ALK-rearranged non-small cell lung cancer and brain metastases in profile 1005 and profile 1007
    Meeting Abstract

    Costa, D. B.; Shaw, A. T.; Ou, S. H. I.; Solomon, B. J.; Riely, G. J.; Ahn, M. J.; Zhou, C. C.; Shreeve, S. M.; Wiltshire, R.; Selaru, P.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save